Diagnosis of NALFD

A 70-year-old non-smoker male was referred to a hospital after elevated levels of liver enzymes were detected during a routine check-up. The patient had a medical history of hypertension and dyslipidemia, for which he was taking Valsartan 80 mg/day for more than 10 years. He was also overweight, with a BMI of 26.4 kg/m2. The patient had not been taking any medication for dyslipidemia due to a history of statin-induced myositis. His physical examination was normal except for an obese abdomen. The patient tested negative for hepatitis B and C. The transient elastography analysis (Fibroscan®) showed liver stiffness of 4.6 kPa but a controlled attenuation parameter of 305 db/m. The liver function test was conducted which revealed elevated levels of ALT and AST. However, bilirubin, glucose, and cholesterol levels were normal.